[
    [
        {
            "time": "2018-07-27",
            "original_text": "Pre-Market Earnings Report for July 27, 2018: XOM, CVX, MRK, ABBV, CL, PSX, AON, MCO, TWTR, IMO, WY, SYF",
            "features": {
                "keywords": [
                    "Earnings",
                    "Pre-Market",
                    "MRK",
                    "ABBV"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "energy",
                    "pharmaceuticals",
                    "consumer goods"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pre-Market Earnings Report for July 27, 2018: XOM, CVX, MRK, ABBV, CL, PSX, AON, MCO, TWTR, IMO, WY, SYF",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "Notable ETF Inflow Detected - IUSG, ABBV, CRM, PYPL",
            "features": {
                "keywords": [
                    "ETF",
                    "Inflow",
                    "IUSG",
                    "ABBV"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "financial services"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Notable ETF Inflow Detected - IUSG, ABBV, CRM, PYPL",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "AbbVie Q2 Earnings Preview",
            "features": {
                "keywords": [
                    "Q2",
                    "Earnings",
                    "Preview",
                    "ABBV"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "AbbVie Q2 Earnings Preview",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "How Gilead Sciences Fared in the Second Quarter",
            "features": {
                "keywords": [
                    "Gilead",
                    "Sciences",
                    "Second Quarter"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "How Gilead Sciences Fared in the Second Quarter",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "Stryker Reports Revenue Growth of 10.3% in Second Quarter",
            "features": {
                "keywords": [
                    "Stryker",
                    "Revenue Growth",
                    "10.3%",
                    "Second Quarter"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "medical devices"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Stryker Reports Revenue Growth of 10.3% in Second Quarter",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "ABBV, MRK Q2 Earnings on Jul 27: Here are the Key Predictions",
            "features": {
                "keywords": [
                    "ABBV",
                    "MRK",
                    "Q2",
                    "Earnings",
                    "Predictions"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "ABBV, MRK Q2 Earnings on Jul 27: Here are the Key Predictions",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]